BPA Call 75N91020A00003-75N91020F00001
Award Date
9/24/20
Potential Completion Date
9/23/21
Potential Value
$160K
Federal Agency
National Cancer Institute
Awardee
Department Of Health
Ultimate Awardee
Not listed
NAICS Category
541713 - Research and Development in Nanotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The $185,877.28 contract provides the NCI's Division of Cancer Epidemiology and Genetics (DCEG) with a one-year license to access the Clinical Practice Research Datalink (CPRD) medical records database, which contains...
This firm fixed price Blanket Purchase Agreement (BPA) call award from the Department of Health and Human Services' National Institutes of Health's National Cancer Institute provides the prime contractor, the United Kingdom's Department of Health known as the Medicines & Healthcare Products Regulatory Agency, with a license to access the Clinical Practice Research Datalink (CPRD) National Cancer Data Registry (NCDR) database. Valued at one hundred seventy-three thousand one hundred...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $12,571.47 firm fixed price call against a blanket purchase agreement to the Medicines & Healthcare Products Regulatory Agency, doing business as the Department of Health, located in Great Britain, United Kingdom. The contract is for regulatory services to be delivered by September 22, 2021 in support of the National Cancer Institute's research efforts. No set aside designation...
This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The contract provides the NCI with access to the Clinical Practice Research Datalink (CPRD) database and linkages to the National Cancer Data Registry, to support the NCI's epidemiological cancer research. Specific studies will...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price contract valued at fifteen thousand two hundred eighty-one dollars to the Department of Health Medicines & Healthcare Products Regulatory Agency. The contract calls for linking clinical practice data from the Clinical Practice Research Datalink to the National Cancer Data Registry database to study the relationship between hormone therapy and risks of secondary...
The Department of Health and Human Services' National Institutes of Health's National Cancer Institute awarded a firm fixed price task order worth $15,281 under an unspecified government-wide acquisition contract vehicle to the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The task order calls for linking clinical practice data from the Clinical Practice Research Datalink to the National Cancer Data Registry database to study reproductive risk...
This is a definitive contract awarded by the Food and Drug Administration (FDA) to the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency (MHRA), a UK government agency. The contract, valued at $2,816,500.00, is for the recompete of the General Practice Research Division within the MHRA. It is a firm fixed price contract with no set-aside designation. The contract provides access to the Clinical Practice Research Datalink (CPRD) database and...
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a $12,000 firm fixed price purchase order to UK Biobank Limited. The purpose of this contract is to provide Dr. Stewart and his team access to biobank data including whole exome and genome data on 500,000 individuals linked to electronic health records within UK Biobank. This will support analysis of the frequency, phenotypic spectrum, and penetrance...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $24,000 purchase order to Biocytogen Boston Corporation for B-HIL2RA MICE (110066) LICENSE. Under this firm fixed price contract, Biocytogen Boston will deliver a license for the specified mice to support the NIH NCI's cancer research efforts. No major subcontractors or set aside designations were identified. The one month period of performance from September 13, 2023 through October...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a one-year, firm fixed price purchase order valued at fourteen thousand four hundred ninety dollars to Certara USA Inc. for software licenses. Certara will provide the licenses to the NIH NCI in support of its mission to conduct and coordinate research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer,...